Skip to main content
Premium Trial:

Request an Annual Quote

Becton Dickinson Posts 11-Percent Rise in Fiscal Q2 Revenue as R&D Spend Falls and Profit Jumps

NEW YORK (GenomeWeb News) — Becton Dickinson today said that fiscal second-quarter revenues rose 11 percent as R&D spending decreased 32 percent and profit swelled 57 percent.
 
Total receipts for the three months ended March 31 increased to $1.6 billion from $1.4 billion year over year.
 
BD said revenues from its Diagnostics segment increased 11 percent to $473 million, while Biosciences revenue rose 13 percent to $258.5 million. Revenue from the Medical segment rose 10 percent to $844.1 million.  
 
The company also said that Tripath Imaging, which BD acquired late last year, contributed $27 million in second quarter sales.
  
R&D spending for the quarter decreased to $86.7 million from $127.7 million year over year.
 
Net profits for the quarter increased to $242.5 million from $154.1 million in the year-ago period.
 
The company did not disclose its balance sheet for the period.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.